Melatonin- and Ferulic Acid-Based HDAC6 Selective Inhibitors Exhibit Pronounced Immunomodulatory Effects In Vitro and Neuroprotective Effects in a Pharmacological Alzheimer’s Disease Mouse Model
Open accessThe DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
The structures of melatonin and ferulic acid were merged into tertiary amide-based histone deacetylase 6 (HDAC6) inhibitors to develop multi-target-directed inhibitors for neurodegenerative diseases to incorporate antioxidant effects without losing affinity and selectivity at HDAC6. Structure-activity relationships led to compound 10b as a hybrid molecule showing pronounced and selective inhibition of HDAC6 (IC50 = 30.7 nM, > 25-fold selectivity over other subtypes). This compound shows comparable DPPH radical scavenging ability to ferulic acid, comparable ORAC value to melatonin and comparable Cu 2+ chelating ability to EDTA. It also lacks neurotoxicity on HT-22 cells, exhibits a pronounced immunomodulatory effect, and is active in vivo showing significantly higher efficacy in an AD mouse model to prevent both Aβ25−35-induced spatial working and long-term memory dysfunction at lower dose (0.3 mg/kg) compared to positive control HDAC6 inhibitor ACY1215 and an equimolar mixture of the three entities ACY1215, melatonin and ferulic acid, suggesting potentially disease-modifying properties.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. Cohen
Jones, G., Willett, P., Glen, R. C., Leach, A. R., & Taylor, R. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0897 · Cited by 6,763
Improved protein–ligand docking using GOLD
Verdonk, M. L., Cole, J. C., Hartshorn, M. J., Murray, C. W., & Taylor, R. D. (2003) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.10465 · Cited by 3,067
Ou, B., Hampsch-Woodill, M., & Prior, R. L. (2001) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf010586o · Cited by 2,932
Inflammation as a central mechanism in Alzheimer's disease
Kinney, J. W., Bemiller, S. M., Murtishaw, A. S., Leisgang, A. M., Salazar, A. M., & Lamb, B. T. (2018) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2018.06.014 · Cited by 2,253
DPPH antioxidant assay revisited
Sharma, O. P., & Bhat, T. K. (2009) · Food Chemistry · doi:10.1016/j.foodchem.2008.08.008 · Cited by 1,969
Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease.
(2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2305-5839.2015.03.49 · Cited by 1,288
Extending Applicability of the Oxygen Radical Absorbance Capacity (ORAC−Fluorescein) Assay
Dávalos, A., Gómez-Cordovés, C., & Bartolomé, B. (2004) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0305231 · Cited by 1,207
Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight
Ho, T. C. S., Chan, A. H. Y., & Ganesan, A. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00830 · Cited by 795
Santo, L., Hideshima, T., Kung, A. L., Tseng, J.-C., Tamang, D., Yang, M., Jarpe, M., van Duzer, J. H., Mazitschek, R., Ogier, W. C., et al. (2012) · Blood · doi:10.1182/blood-2011-10-387365 · Cited by 616
Maurice, T., Lockhart, B. P., & Privat, A. (1996) · Brain Research · doi:10.1016/0006-8993(95)01032-7 · Cited by 521
Self-citationPolypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds
Proschak, E., Stark, H., & Merk, D. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00760 · Cited by 498
Histone deacetylase 6 interacts with the microtubule‐associated protein tau
Ding, H., Dolan, P. J., & Johnson, G. V. W. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05564.x · Cited by 387
Metal Ions in Alzheimer’s Disease: A Key Role or Not?
Liu, Y., Nguyen, M., Robert, A., & Meunier, B. (2019) · Accounts of Chemical Research · doi:10.1021/acs.accounts.9b00248 · Cited by 353
Biological metals and Alzheimer's disease: Implications for therapeutics and diagnostics
Duce, J. A., & Bush, A. I. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.04.003 · Cited by 283
Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms
Zhou, J., Jiang, X., He, S., Jiang, H., Feng, F., Liu, W., Qu, W., & Sun, H. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00017 · Cited by 281
DSX: A Knowledge-Based Scoring Function for the Assessment of Protein–Ligand Complexes
Neudert, G., & Klebe, G. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci200274q · Cited by 264
Santos, J. S., Alvarenga Brizola, V. R., & Granato, D. (2017) · Food Chemistry · doi:10.1016/j.foodchem.2016.07.091 · Cited by 245
Peptoid architectures: elaboration, actuation, and application
Yoo, B., & Kirshenbaum, K. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2008.08.015 · Cited by 218
Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's disease
Savaskan, E., Ayoub, M. A., Ravid, R., Angeloni, D., Fraschini, F., Meier, F., Eckert, A., Müller‐Spahn, F., & Jockers, R. (2005) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2004.00169.x · Cited by 205
Bergman, J. A., Woan, K., Perez-Villarroel, P., Villagra, A., Sotomayor, E. M., & Kozikowski, A. P. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301098e · Cited by 195
Histone deacetylases in memory and cognition
Penney, J., & Tsai, L.-H. (2014) · Science Signaling · doi:10.1126/scisignal.aaa0069 · Cited by 190
Unusual zinc-binding mode of HDAC6-selective hydroxamate inhibitors
Porter, N. J., Mahendran, A., Breslow, R., & Christianson, D. W. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718823114 · Cited by 190
Albertini, C., Salerno, A., de Sena Murteira Pinheiro, P., & Bolognesi, M. L. (2021) · Medicinal Research Reviews · doi:10.1002/med.21699 · Cited by 179
Increased melatonin 1a‐receptor immunoreactivity in the hippocampus of Alzheimer's disease patients
Savaskan, E., Olivieri, G., Meier, F., Brydon, L., Jockers, R., Ravid, R., Wirz‐Justice, A., & Müller-Spahn, F. (2002) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2002.00841.x · Cited by 152
Epigenetic polypharmacology: A new frontier for epi‐drug discovery
Tomaselli, D., Lucidi, A., Rotili, D., & Mai, A. (2019) · Medicinal Research Reviews · doi:10.1002/med.21600 · Cited by 136
Harnessing Polypharmacology with Medicinal Chemistry
Bolognesi, M. L. (2019) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00039 · Cited by 130
Brindisi, M., Saraswati, A. P., Brogi, S., Gemma, S., Butini, S., & Campiani, G. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00924 · Cited by 125
In vitro assays for the determination of histone deacetylase activity
Heltweg, B., Trapp, J., & Jung, M. (2005) · Methods · doi:10.1016/j.ymeth.2005.03.003 · Cited by 116
Porter, N. J., Osko, J. D., Diedrich, D., Kurz, T., Hooker, J. M., Hansen, F. K., & Christianson, D. W. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01013 · Cited by 111
Cuadrado‐Tejedor, M., García, C., Sánchez-Arias, J. A., Rabal, O., Pérez-González, M., Mederos, S., Ugarte, A., Franco, R., Segura, V., Perea, G., et al. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.163 · Cited by 108
Fan, S.-J., Huang, F.-I., Liou, J., & Yang, C. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0688-5 · Cited by 106
Hoffmann, M., Stiller, C., Endres, E., Scheiner, M., Gunesch, S., Sotriffer, C., Maurice, T., & Decker, M. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01012 · Cited by 105
Self-citationA patent review of histone deacetylase 6 inhibitors in neurodegenerative diseases (2014-2019)
Shen, S., & Kozikowski, A. P. (2019) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2019.1708901 · Cited by 98
Rabal, O., Sánchez-Arias, J. A., Cuadrado‐Tejedor, M., de Miguel, I., Pérez-González, M., García, C., Ugarte, A., de Mendoza, A. E., Sáez, E., Espelosin, M., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00908 · Cited by 94
Li, X., Peterson, Y. K., Inks, E. S., Himes, R. A., Li, J., Zhang, Y., Kong, X., & Chou, C. J. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00136 · Cited by 93
Self-citationGunesch, S., Hoffmann, M., Kiermeier, C., Fischer, W. H., Pinto, A. F. M., Maurice, T., Maher, P. A., & Decker, M. W. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101378 · Cited by 89
Self-citationNovel HDAC6 isoform selective chiral small molecule histone deacetylase inhibitors
Smil, D. V., Manku, S., Chantigny, Y., Leit, S. M., Wahhab, A., Yan, T. P., Fournel, M., Maroun, C. R., Li, Z., Lemieux, A., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.12.045 · Cited by 84
Complex neuroprotective and neurotoxic effects of histone deacetylases
Thomas, E. A., & D’Mello, S. R. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14309 · Cited by 83
Lee, H., Fan, S.-J., Huang, F.-I., Chao, H.-Y., Hsu, K., Lin, T. E., Yeh, T., Lai, M.-J., Li, Y.-H., Huang, H.-L., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00151 · Cited by 77
Simone, A. D., & Milelli, A. (2019) · ChemMedChem · doi:10.1002/cmdc.201900174 · Cited by 76
Simone, A. D., Pietra, V. L., Betari, N., Petragnani, N., Conte, M., Daniele, S., Pietrobono, D., Martini, C., Petralla, S., Casadei, R., et al. (2019) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.8b00507 · Cited by 60
Self-citationOsko, J. D., Porter, N. J., Poli, A. N. R., Xiao, Y., Rokka, J., Jung, M., Hooker, J. M., Salvino, J. M., & Christianson, D. W. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01540 · Cited by 58
Rational design and diversity-oriented synthesis of peptoid-based selective HDAC6 inhibitors
Diedrich, D., Hamacher, A., Gertzen, C. G. W., Avelar, L. A. A., Reiß, G. J., Kurz, T., Gohlke, H., Kassack, M. U., & Hansen, F. K. (2016) · Chemical Communications · doi:10.1039/c5cc10301k · Cited by 53
Tseng, H.-J., Lin, M.-H., Shiao, Y.-J., Yang, Y.-C., Chu, J.-C., Chen, C.-Y., Chen, Y.-Y., Lin, T. E., Su, C.-J., Pan, S.-L., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112193 · Cited by 53
Rabal, O., Sánchez-Arias, J. A., Cuadrado‐Tejedor, M., de Miguel, I., Pérez-González, M., García, C., Ugarte, A., de Mendoza, A. E., Sáez, E., Espelosin, M., et al. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00303 · Cited by 50
Ferulic Acid and Alzheimer’s Disease: Promises and Pitfalls
Nabavi, S. F., Kasi, D., Malar, D. S., Sureda, A., Daglia, M., & Nabavi, S. F. (2015) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557515666150522102545 · Cited by 49
Scheiner, M., Dolles, D., Gunesch, S., Hoffmann, M., Nabissi, M., Marinelli, O., Naldi, M., Bartolini, M., Petralla, S., Poeta, E., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00623 · Cited by 49
Self-citationTwo-hit wonders: The expanding universe of multitargeting epigenetic agents
de Lera, Á. R., & Ganesan, A. (2020) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2020.05.009 · Cited by 48
Bifunctional HDAC Therapeutics: One Drug to Rule Them All?
Smalley, J. P., Cowley, S. M., & Hodgkinson, J. T. (2020) · Molecules · doi:10.3390/molecules25194394 · Cited by 48
Krieger, V., Hamacher, A., Gertzen, C. G. W., Senger, J., Zwinderman, M. R. H., Marek, M., Romier, C., Dekker, F. J., Kurz, T., Jung, M., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00197 · Cited by 46
Therapeutic potential of neurogenesis and melatonin regulation in Alzheimer's disease
Mihardja, M., Roy, J., Wong, K. Y., Aquili, L., Heng, B. C., Chan, Y., Fung, M., & Lim, L. W. (2020) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14436 · Cited by 45
Gaisina, I. N., Lee, S., Kaidery, N. A., Aissa, M. B., Ahuja, M., Smirnova, N. N., Wakade, S., Gaisin, A. M., Bourassa, M. W., Ratan, R. R., et al. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00435 · Cited by 41
Xu, A., He, F., Zhang, X., Li, X., Ran, Y., Wei, C., Chou, C. J., Zhang, R., & Wu, J. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.103721 · Cited by 40
Self-citationConrad, M., Schick, J., & Angeli, J. P. F. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.01.010 · Cited by 38
Development of novel ferulic acid derivatives as potent histone deacetylase inhibitors
Wang, F., Lu, W. Z., Zhang, T., Dong, J., Gao, H., Li, P., Wang, S., & Zhang, J. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.09.021 · Cited by 38
He, F., Ran, Y., Li, X., Wang, D., Zhang, Q., Lv, J., Yu, C., Qu, Y., Zhang, X., Xu, A., et al. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104109 · Cited by 34
Self-citationSong, Y., Li, Q., Yang, R., Yang, F., Kenechukwu, N. A., Zhao, X., Zhou, X., Wen, X., & Li, L. (2019) · Pharmaceutical Biology · doi:10.1080/13880209.2018.1563620 · Cited by 34
Cheng, T., Grasse, L., Shah, J., & Chandra, J. (2015) · Drugs of Today · doi:10.1358/dot.2015.51.8.2362311 · Cited by 32
Modulation of Immune Responses by Histone Deacetylase Inhibitors
Schötterl, S., Brennenstuhl, H., & Naumann, U. (2014) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2014012393 · Cited by 30
Gu, L., Cui, X., Wei, W., Yang, J. H., & Li, X. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.09.015 · Cited by 25
Wang, X., Li, X., Li, J., Hou, J., Qu, Y., Yu, C., He, F., Xu, W., & Wu, J. (2016) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12819 · Cited by 22
Self-citationA simple, cheap but reliable method for evaluation of zinc chelating properties
Catapano, M. C., Tvrdý, V., Karlíčková, J., Mercolini, L., & Mladěnka, P. (2018) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2018.01.015 · Cited by 19
Couly, S., Denus, M., Bouchet, M., Rubinstenn, G., & Maurice, T. (2020) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa075 · Cited by 19
Self-citationGunesch, S., Soriano‐Castell, D., Lamer, S., Schlösser, A., Maher, P. A., & Decker, M. W. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00589 · Cited by 16
Self-citationAntioxidant and Anti-Inflammatory Role of Melatonin in Alzheimer’s Neurodegeneration
Rosales‐Corral, S., Reiter, R. J., Tan, D., Manchester, L. C., & Liu, X. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405933-7.00018-4 · Cited by 15
Cited by
Zhang, J., Zhang, Y., Wang, J., Xia, Y., Zhang, J., & Chen, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01911-3 · Cited by 1,138
“513 Compound 39 achieved strong HDAC6 selectivity through interaction with another speci fi c pocket on HDAC6, inhibiting tau hyperphosphorylation and aggregation.”
BackgroundMelatonin in Cancer Treatment: Current Knowledge and Future Opportunities
Talib, W. H., Alsayed, A. R., Abuawad, A., Daoud, S., & Mahmod, A. I. (2021) · Molecules · doi:10.3390/molecules26092506 · Cited by 210
“Besides, it shows immunomodulation and neuroprotective potential in a pharmacological Alzheimer’s disease mouse model [41].”
BackgroundZhang, H., Zhang, Y., Li, Y., Wang, Y., Yan, S., Xu, S., Deng, Z., Yang, X., Xie, H., & Li, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.756550 · Cited by 104
Li, Y., Sang, S., Ren, W., Pei, Y., Bian, Y., Chen, Y., & Sun, H. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113874 · Cited by 77
Photoinduced ynamide structural reshuffling and functionalization
Mutra, M. R., & Wang, J. (2022) · Nature Communications · doi:10.1038/s41467-022-30001-7 · Cited by 51
Metadata
- Authors
- He, F., Chou, C. J., Scheiner, M., Poeta, E., Yuan Chen, N., Gunesch, S., Hoffmann, M., Sotriffer, C., Monti, B., Maurice, T., & Decker, M.
- Affiliations
- University of Würzburg (DE)
- Medical University of South Carolina (US)
- University of Bologna (IT)
- Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy and Food Chemistry, Julius Maximilian University of Würzburg, Am Hubland, Würzburg 97074, Germany
- Inserm (FR)
- Corresponding author
- Maurice, Tangui
- Decker, Michael
- ORCID
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2021-03-26
- Volume
- 64
- Issue
- 7
- Pages
- 3794-3812
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W3136159689
- Cited by
- 66
- References
- 65
- Citations by year
- 2026: 5 · 2025: 13 · 2024: 15 · 2023: 10 · 2022: 14 · 2021: 9
- FWCI
- 4.16
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- Locations
- Journal of Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, other-oa)
- Funders
- Bundesministerium f?r Bildung und Forschung (57387204)
- Deutscher Akademischer Austauschdienst
- Campus France
- Deutsche Forschungsgemeinschaft (DE1546/6-3)
- Studienstiftung des Deutschen Volkes
- Bayerisch-Franz?sisches Hochschulzentrum (FK03-2020)
- China Scholarship Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- HDAC6 inhibitors, melatonin, ferulic acid, Alzheimer's disease, immunomodulation, neuroprotection, antioxidant activity, amyloid beta 25-35, spatial working memory, long-term memory, disease-modifying therapy, structure-activity relationship, HT22 cells
- MeSH terms
- Histone Deacetylase 6, Alzheimer Disease, Animals, Cell Line, Transformed, Coumaric Acids, Immunologic Factors, Male, Melatonin, Structure-Activity Relationship, Tryptamines, Neuroprotective Agents, Catalytic Domain, Mice, Histone Deacetylase Inhibitors, Molecular Docking Simulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.